Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Health
Jane Kirby

The health benefit of weight-loss jab ‘even before people shed weight’

New data suggests the weight-loss drug Wegovy may significantly reduce the risk of heart disease even before users experience substantial weight loss.

The drug, containing semaglutide, curbs appetite and is available through the NHS for individuals with a high BMI, as well as from private providers.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.